Synergistic interference with SARS-CoV-2 replication by Molnupiravir-derived N4 hydroxycytidine and inhibitors of CTP synthetase
Kim M. Stegmann, Antje Dickmanns, Hannah L Fuchs, David Scheibner, Björn-Patrick Mohl, Florian R Moeselaken, Wencke Reineking, Theresa Störk, Asisa Volz, Philip A. Beer, Andrew Parker, Veronika Pilchová, Christian Meyer zu Natrup, Maren von Köckritz-Blickwede, Wolfgang Baumgärtner, , Matthias Dobbelstein
This paper shows that combining N4-hydroxycytidine with CTP synthetase inhibitors strongly reduces SARS-CoV-2 replication in cell culture and animal models.
bioRxiv · Mar 6, 2025 · PreprintMicrobiology